Medical and Pharmaceutical Industry - Market Research Report

  According to a recent report by Grand View Research, Inc., the global   mobile device management (MDM) market   is projected to reach USD 28.37 billion by 2030, expanding at a CAGR of 24.5% from 2025 to 2030. This growth is primarily attributed to the increasing use of mobile devices in the workplace and the growing need to manage and secure them effectively. As smartphones, tablets, and other mobile devices become more prevalent, employees are increasingly using their personal devices for work—an approach known as Bring Your Own Device (BYOD). This trend is contributing to the rising number of mobile devices requiring centralized oversight and protection. MDM solutions offer organizations a unified platform to oversee and secure mobile devices, enabling functions such as security policy enforcement, device usage monitoring, and remote data wiping in cases of loss or theft. As companies continue to implement BYOD strategies or issue corporate devices to employees, deman...

  The global   medical polymer market   is projected to reach USD 36.77 billion by 2030, growing at a CAGR of 8.0%, according to a recent report by Grand View Research, Inc. This growth is primarily attributed to the increasing adoption of polymers in medical implants due to their chemical inertness and excellent fatigue resistance. Furthermore, the growing demand for in-house and advanced medical devices is expected to boost the need for medical device packaging. High healthcare spending, especially in countries such as the U.S., China, and Germany, is anticipated to support the expansion of various application segments in the coming years. Additionally, the global rise in COVID-19 cases has increased the demand for medical devices, which in turn is fueling the medical polymer market. The raw materials used in medical polymer production include ethylene, propylene, caprolactam, corn starch, and silica stone (SiO2). Silica stone, a major element of the Earth's crust, is o...

  According to a recent study by Grand View Research, Inc., the global  small molecule CDMO (Contract Development and Manufacturing Organization) market  is projected to reach USD 108.46 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2030. Key factors driving this growth include the adoption of innovative technologies in small molecule drug development, the expansion of pharmaceutical pipelines focused on small molecule therapies, and the increasing reliance on CDMOs for their cost-efficiency and specialized services. Regulatory support for streamlined drug development and manufacturing processes, along with CDMOs scaling up their production capacities to meet growing industry needs, also contribute significantly to market expansion. For pharmaceutical companies, innovation and ease of access to clinical solutions remain essential. Specialty pharmaceutical firms and small-scale players are playing a pivotal role in meeting these cr...

  According to a recent report by Grand View Research, Inc., the global   hemodialysis and peritoneal dialysis market   is projected to reach USD 185.88 billion by 2030, expanding at a compound annual growth rate (CAGR) of 9.1% over the forecast period. This growth is driven by the rising incidence of renal diseases and a growing elderly population, both of which are increasing global demand for hemodialysis and peritoneal dialysis. Additionally, heightened investment in the development of innovative products is expected to create favorable market conditions. The COVID-19 pandemic significantly impacted the healthcare sector, leading to increased hospitalizations and the emergence of infection hotspots. During this period, the global need for Renal Replacement Therapy (RRT) rose, largely due to a higher prevalence of comorbidities such as Chronic Kidney Disease (CKD), diabetes, and hypertension. Consequently, the demand for dialysis machines surged. A study published by t...

  The global   vascular access devices market   is projected to reach USD 11.49 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2030. This growth is driven by an aging population, a rising prevalence of chronic diseases, and an increasing number of surgical procedures. Vascular access devices enable access to the vascular system for the administration or withdrawal of fluids, medications, and blood. These devices are commonly used in the treatment of serious medical conditions such as cancer and kidney failure. The rising incidence of chronic illnesses is expected to further boost demand for vascular access devices. Moreover, continuous technological advancements in medical equipment are likely to support market expansion. The growing burden of chronic diseases—including cancer, kidney disorders, cardiovascular diseases, hypertension, diabetes, obesity, and depression—has significantly contributed to the increase in cancer cases. Acco...

  The   U.S. Medical Weight Loss Clinics market   is projected to reach USD 1.50 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.42% from 2025 to 2030, according to a recent report by Grand View Research, Inc. This growth is primarily driven by the increasing prevalence of obesity and the rising number of overweight adults in the U.S. Additionally, a growing awareness and desire among this population to improve their overall health is expected to further support market expansion. Physical inactivity remains a significant public health issue in the U.S., contributing to the second-highest number of deaths after tobacco use. A sedentary lifestyle is a key contributor to obesity, which often leads to serious health complications such as diabetes and heart disease. Consequently, the increasing rate of physical inactivity among U.S. adults is expected to propel market growth over the forecast period. Data from the CDC indicates that approximately 15% of a...

  The global   urinary catheters market   size was valued at USD 5.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. An increase in the number of patients suffering from Urinary Tract Infections (UTIs) and blockages in the urethra, rising cases of tumors in the urinary tract or reproductive organs, and the rapidly growing geriatric population are some of the key factors driving the market growth. A urinary catheter is a partially flexible tube for draining urine from the bladder. The materials that are used in the manufacturing of these catheters include plastic, rubber, and silicon. Doctors recommend the use of urinary catheters in the case of Urinary Incontinence (UI), urinary retention, prostate surgery, or other medical conditions, such as spinal cord injury, multiple sclerosis, or dementia. The COVID-19 is expected to have a positive impact on catheters market. According to National Center for Biotechnology I...

  The   South East Asia advanced wound care market   size was valued at USD 221.28 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.11% from 2023 to 2030. The rising prevalence of chronic diseases, mainly, diabetes and obesity, is one of the key factors leading to an increase in the incidence of chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers. For instance, as per data published by the government of Singapore (Ministry of Health), as of December 2021, a study showed that diabetes contributed to 87% of arterial insufficiency ulcers in the population of Singapore. Similarly, according to IDF Diabetes Atlas, Indonesia ranked 5th in 2019 with around 7.9 million adults aged between 20 and 79 having undiagnosed diabetes. Healing of these chronic wounds requires advanced wound care products, thus, impelling the growth of the market over the forecast period.  The rising prevalence of obesity is another...

  The global   drug-device combination products market   was valued at USD 138.47 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2030. Key factors driving this growth include technological advancements, rising demand for minimally invasive drug delivery systems, increasing prevalence of chronic conditions like diabetes, and a growing elderly population. According to the International Diabetes Federation (IDF), approximately 537 million adults aged 20–79 were living with diabetes in 2021. This number is projected to rise to 783 million by 2045. The IDF also noted that nearly 90% of individuals with diabetes are at increased risk of developing type 2 diabetes. The market is experiencing significant innovation and expansion, fueled by the potential of combination medical products to enhance treatment for various diseases. Breakthroughs in drug delivery technologies—particularly in targeting specific areas and extending...

  The global   antimicrobial resistance (AMR) diagnostics market   was valued at USD 4.60 billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 6.55% from 2025 to 2030. Market growth is primarily driven by the high prevalence of pathogens such as   Streptococcus pneumoniae , MRSA, and   Clostridioides difficile , along with a rising incidence of AMR infections. Additionally, growing demand for advanced diagnostic technologies and increasing regulatory approvals are accelerating market development. For instance, in September 2021, MeMed’s BV diagnostic test—designed to distinguish between bacterial and viral infections in point-of-care settings—received 510(k) clearance from the U.S. FDA. The escalating threat posed by antimicrobial resistance continues to be a key market driver. According to the CDC, approximately 2.8 million AMR infections occur annually in the U.S., while the United States Pharmacopeial Convention estimates that...

  The   U.S. medical billing outsourcing market   was valued at USD 6.28 billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 12.00% from 2025 to 2030. The increasing complexity in handling a high volume of claims and reimbursements has led to notable revenue losses for healthcare providers, thereby driving the demand for medical billing outsourcing services in the U.S. Additionally, the growing patient load and administrative burden associated with managing extensive records and billing responsibilities have prompted healthcare practitioners to seek external support. Hospitals are increasingly outsourcing medical billing functions to manage these challenges more effectively, which is expected to support market growth. Hospitals typically partner with outsourcing firms possessing comprehensive knowledge of the Affordable Care Act, Medicaid, and other healthcare and insurance systems. The industry has also witnessed a surge in outsourcing b...

  The global   medical equipment maintenance market  was valued at   USD 41.90 billion in 2023   and is projected to expand at a   CAGR of 10.0% from 2024 to 2030. The market’s growth is driven by the rising global demand for medical devices, the increasing prevalence of life-threatening conditions requiring diagnostic procedures, and the growing need for refurbished medical equipment. Given the critical role of medical equipment in healthcare delivery, the effectiveness of treatments largely depends on the precision and performance of these devices. A wide range of equipment—such as electrocardiographs, syringe pumps, centrifuges, X-ray machines, autoclaves, and ultrasound devices—are used across healthcare settings for diagnosis and treatment. Due to continuous use, these devices require regular maintenance to address wear, malfunctions, and potential defects. In 2023, imaging equipment led the market, accounting for 36.1% of total market share....

The pharmaceutical industry is transforming, especially after COVID-19. Over the past decade, the field of drug discovery has been radically transformed due to advancements in artificial intelligence (AI). These revolutionary technologies for medicine design are making breakthroughs to overcome the traditional lengthy drug discovery processes. Traditional drug discovery often costs billions of dollars, taking over a decade and costing billions of dollars to bring a new drug to market. However, AI is changing the game by making drug discovery faster, more efficient, and cost-effective. Traditional drug discovery, on average, requires 2 to 3 billion US dollars to develop a new drug in around 10 years. The rise of AI has turned over a new leaf and revolutionized drug discovery by analyzing large amounts of biological and chemical data to identify promising drug candidates. Machine learning (ML) algorithms, deep learning techniques, and natural language processing (NLP) are being used to p...